EMPAVELI
EMPAVELI
Approved
DIN Number
02533294
Drug Class
Human
Market Date
Feb 15, 2023
Company
HC
Swedish Orphan Biovitrum AB (Publ)
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02533294
AIG Number0164341001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
L04AJ03 PEGCETACOPLAN
Product Specifications
Dosage FormSolution
Route of AdministrationSubcutaneous
AHFS Classification90:20.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
PEGCETACOPLANActive
Strength: 1080 MG / 20 ML
Monograph: PEGCETACOPLAN